NCM Capital Advisers’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$398K Sell
6,000
-491
-8% -$33.6K 1.19% 43
2016
Q2
$470K Hold
6,491
1.35% 35
2016
Q1
$419K Hold
6,491
1.21% 43
2015
Q4
$465K Hold
6,491
1.32% 36
2015
Q3
$498K Sell
6,491
-6,859
-51% -$553K 1.47% 27
2015
Q2
$989K Hold
13,350
1.32% 30
2015
Q1
$968K Hold
13,350
1.3% 27
2014
Q4
$883K Buy
13,350
+4,950
+59% +$302K 1.24% 31
2014
Q3
$460K Hold
8,400
0.69% 67
2014
Q2
$488K Hold
8,400
0.72% 64
2014
Q1
$521K Sell
8,400
-4,800
-36% -$279K 0.82% 61
2013
Q4
$705K Sell
13,200
-2,500
-16% -$134K 0.73% 64
2013
Q3
$788K Buy
15,700
+5,100
+48% +$249K 0.87% 51
2013
Q2
$485K Buy
+10,600
New +$474K 0.46% 79

Other funds holding MD

NCM Capital Advisers's MD Position: Q3 2016 in Review

NCM Capital Advisers reduced its Pediatrix Medical (MD) stake by 7.6% in Q3 2016, selling an estimated $33.6K and leaving 6,000 shares worth $398K. The position accounts for 1.19% of the portfolio, ranked #43.

NCM Capital Advisers first reported a position in MD in Q2 2013 and has held it in 14 quarters since. The position peaked at $989K in Q2 2015. 381 funds tracked by Wall St. Rank hold MD as of Q3 2016.

  • NCM Capital Advisers held 6,000 shares of Pediatrix Medical worth $398K as of Q3 2016.
  • NCM Capital Advisers sold 491 Pediatrix Medical shares in Q3 2016, an estimated $33.6K.
  • Pediatrix Medical made up 1.19% of NCM Capital Advisers's portfolio in Q3 2016, its #43 holding.
  • NCM Capital Advisers first reported a position in Pediatrix Medical in Q2 2013 and has held it in 14 quarters since.
  • NCM Capital Advisers's Pediatrix Medical position peaked at $989K in Q2 2015.
  • 381 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2016.

Based on NCM Capital Advisers's 13F filing for Q3 2016, filed 7 Nov 2016.